HomeCompareNXU vs MRK

NXU vs MRK: Dividend Comparison 2026

NXU yields 81.63% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NXU wins by $1.73M in total portfolio value
10 years
NXU
NXU
● Live price
81.63%
Share price
$2.45
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.78M
Annual income
$523,166.96
Full NXU calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — NXU vs MRK

📍 NXU pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNXUMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NXU + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NXU pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NXU
Annual income on $10K today (after 15% tax)
$6,938.78/yr
After 10yr DRIP, annual income (after tax)
$444,691.92/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, NXU beats the other by $436,363.51/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NXU + MRK for your $10,000?

NXU: 50%MRK: 50%
100% MRK50/50100% NXU
Portfolio after 10yr
$920.3K
Annual income
$266,482.55/yr
Blended yield
28.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

NXU
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
-2.6
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NXU buys
0
MRK buys
0
No recent congressional trades found for NXU or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNXUMRK
Forward yield81.63%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$1.78M$56.8K
Annual income after 10y$523,166.96$9,798.13
Total dividends collected$1.55M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: NXU vs MRK ($10,000, DRIP)

YearNXU PortfolioNXU Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$18,863$8,163.27$11,206$366.19+$7.7KNXU
2$34,575$14,391.20$12,650$502.35+$21.9KNXU
3$61,647$24,652.29$14,407$694.19+$47.2KNXU
4$107,042$41,079.72$16,585$967.82+$90.5KNXU
5$181,198$66,663.01$19,342$1,363.89+$161.9KNXU
6$299,345$105,462.85$22,913$1,947.19+$276.4KNXU
7$483,129$162,829.66$27,662$2,823.89+$455.5KNXU
8$762,555$245,606.91$34,159$4,173.35+$728.4KNXU
9$1,178,231$362,297.08$43,337$6,308.80+$1.13MNXU
10$1,783,874$523,166.96$56,776$9,798.13+$1.73MNXU

NXU vs MRK: Complete Analysis 2026

NXUStock

Nxu, Inc, a technology company, engages in the developing of next-generation electric vehicle charging, battery, and vehicle technologies for mobility customers in the United States. The company offers NxuOne, a charging technology provides repeatable, consistent power delivery, designed to meet the needs of electric vehicles; Nxu battery cell and packs designed to leverage an in-house developed NMC-811 chemistry, combined with proprietary mechanical construction to improve thermal management and reduce electrical resistance. It also provides Nxu EV platform, a modular vehicle system or electric skateboard, which provides technology, software, and mobility technology for vehicle by third parties; and Nxu pickup truck, a flagship vehicle and 100% electric full-sized truck. Nxu, Inc. was incorporated in 2016 and is headquartered in Mesa, Arizona.

Full NXU Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this NXU vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NXU vs SCHDNXU vs JEPINXU vs ONXU vs KONXU vs MAINNXU vs JNJNXU vs ABBVNXU vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.